Perrigo Property, Plant, and Equipment 2010-2025 | PRGO
Perrigo property, plant, and equipment from 2010 to 2025. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
| Perrigo Annual Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024 | $918 |
| 2023 | $916 |
| 2022 | $926 |
| 2021 | $864 |
| 2020 | $865 |
| 2019 | $903 |
| 2018 | $829 |
| 2017 | $833 |
| 2016 | $870 |
| 2015 | $886 |
| 2015 | $932 |
| 2014 | $780 |
| 2013 | $682 |
| 2012 | $578 |
| 2011 | $507 |
| 2010 | $449 |
| 2009 | $354 |
| Perrigo Quarterly Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2025-03-31 | $913 |
| 2024-12-31 | $918 |
| 2024-09-30 | $909 |
| 2024-06-30 | $910 |
| 2024-03-31 | $911 |
| 2023-12-31 | $916 |
| 2023-09-30 | $903 |
| 2023-06-30 | $918 |
| 2023-03-31 | $919 |
| 2022-12-31 | $926 |
| 2022-09-30 | $840 |
| 2022-06-30 | $840 |
| 2022-03-31 | $846 |
| 2021-12-31 | $864 |
| 2021-09-30 | $843 |
| 2021-06-30 | $834 |
| 2021-03-31 | $860 |
| 2020-12-31 | $865 |
| 2020-09-30 | $919 |
| 2020-06-30 | $892 |
| 2020-03-31 | $889 |
| 2019-12-31 | $903 |
| 2019-09-30 | $871 |
| 2019-06-30 | $824 |
| 2019-03-31 | $821 |
| 2018-12-31 | $829 |
| 2018-09-30 | $820 |
| 2018-06-30 | $812 |
| 2018-03-31 | $829 |
| 2017-12-31 | $833 |
| 2017-09-30 | $822 |
| 2017-06-30 | $877 |
| 2017-03-31 | $875 |
| 2016-12-31 | $870 |
| 2016-09-30 | $881 |
| 2016-06-30 | $889 |
| 2016-03-31 | $896 |
| 2015-12-31 | $886 |
| 2015-09-30 | $924 |
| 2015-06-30 | $932 |
| 2015-03-31 | $769 |
| 2014-12-31 | $757 |
| 2014-09-30 | $762 |
| 2014-06-30 | $780 |
| 2014-03-31 | $741 |
| 2013-12-31 | $719 |
| 2013-09-30 | $691 |
| 2013-06-30 | $681 |
| 2013-03-31 | $643 |
| 2012-12-31 | $618 |
| 2012-09-30 | $580 |
| 2012-06-30 | $578 |
| 2012-03-31 | $564 |
| 2011-12-31 | $551 |
| 2011-09-30 | $533 |
| 2011-06-30 | $507 |
| 2011-03-31 | $466 |
| 2010-12-31 | $460 |
| 2010-09-30 | $452 |
| 2010-06-30 | $449 |
| 2010-03-31 | $383 |
| 2009-12-31 | $362 |
| 2009-09-30 | $362 |
| 2009-06-30 | $354 |
| 2009-03-31 | $338 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.704B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.470B | 25.39 |
| Boston Scientific (BSX) | United States | $153.537B | 38.44 |
| Stryker (SYK) | United States | $147.836B | 30.91 |
| EssilorLuxottica (ESLOY) | France | $131.607B | 0.00 |
| Medtronic (MDT) | Ireland | $115.044B | 16.31 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.188B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.812B | 24.44 |
| ResMed (RMD) | United States | $38.280B | 28.75 |
| GE HealthCare Technologies (GEHC) | United States | $33.957B | 16.12 |
| Agilent Technologies (A) | United States | $31.827B | 20.75 |
| Terumo (TRUMY) | Japan | $24.178B | 31.40 |
| Koninklijke Philips (PHG) | Netherlands | $23.630B | 16.58 |
| Insulet (PODD) | United States | $19.773B | 77.61 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.319B | 11.77 |
| Baxter (BAX) | United States | $14.046B | 10.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.647B | 23.13 |
| Lantheus Holdings (LNTH) | United States | $4.951B | 12.49 |
| Prestige Consumer Healthcare (PBH) | United States | $3.734B | 16.68 |
| Haemonetics (HAE) | United States | $3.544B | 16.14 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.300B | 27.42 |
| ICU Medical (ICUI) | United States | $2.994B | 22.08 |
| LeMaitre Vascular (LMAT) | United States | $1.803B | 40.31 |
| QuidelOrtho (QDEL) | United States | $1.711B | 11.77 |
| AtriCure (ATRC) | United States | $1.448B | 0.00 |
| Acuren (TIC) | United States | $1.408B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.251B | 28.13 |
| AdaptHealth (AHCO) | United States | $1.235B | 12.53 |
| Phibro Animal Health (PAHC) | United States | $1.181B | 15.10 |
| Neogen (NEOG) | United States | $1.037B | 13.28 |
| BioLife Solutions (BLFS) | United States | $0.993B | 0.00 |
| InMode (INMD) | Israel | $0.882B | 8.89 |
| Kestra Medical Technologies (KMTS) | United States | $0.854B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.831B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.678B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.606B | 0.00 |
| Owens & Minor (OMI) | United States | $0.598B | 4.96 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| CeriBell (CBLL) | United States | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.540B | 0.00 |
| ZimVie (ZIMV) | United States | $0.522B | 23.75 |
| Surmodics (SRDX) | United States | $0.446B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.305B | 11.22 |
| Cresco Labs (CRLBF) | United States | $0.302B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.286B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.264B | 78.33 |
| Cerus (CERS) | United States | $0.264B | 0.00 |
| Quanterix (QTRX) | United States | $0.259B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.256B | 21.57 |
| OraSure Technologies (OSUR) | United States | $0.243B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.230B | 0.00 |
| Brainsway (BWAY) | Israel | $0.228B | 60.45 |
| Biote (BTMD) | United States | $0.219B | 6.17 |
| Verano Holdings (VRNOF) | United States | $0.213B | 0.00 |
| Omeros (OMER) | United States | $0.213B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.70 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.151B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 14.99 |
| TerrAscend (TSNDF) | Canada | $0.121B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.82 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Safety Shot (SHOT) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.065B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 14.87 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 51.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |